Your browser is no longer supported. Please, upgrade your browser.
BDSI BioDelivery Sciences International, Inc. monthly Stock Chart
BDSI [NASD]
BioDelivery Sciences International, Inc.
Index- P/E- EPS (ttm)-0.09 Insider Own2.30% Shs Outstand97.12M Perf Week13.45%
Market Cap479.28M Forward P/E10.39 EPS next Y0.48 Insider Trans-55.06% Shs Float97.01M Perf Month14.63%
Income-6.50M PEG- EPS next Q0.04 Inst Own76.60% Short Float2.84% Perf Quarter-6.00%
Sales129.90M P/S3.69 EPS this Y74.90% Inst Trans7.14% Short Ratio2.45 Perf Half Y-21.79%
Book/sh0.79 P/B6.25 EPS next Y137.50% ROA-3.60% Target Price8.06 Perf Year11.40%
Cash/sh0.73 P/C6.79 EPS next 5Y25.00% ROE-9.30% 52W Range2.85 - 7.21 Perf YTD-21.91%
Dividend- P/FCF- EPS past 5Y30.30% ROI2.90% 52W High-31.55% Beta0.77
Dividend %- Quick Ratio1.90 Sales past 5Y23.40% Gross Margin82.20% 52W Low73.16% ATR0.28
Employees178 Current Ratio2.20 Sales Q/Q93.40% Oper. Margin8.50% RSI (14)61.27 Volatility5.72% 6.09%
OptionableYes Debt/Eq0.77 EPS Q/Q186.40% Profit Margin-5.00% Rel Volume0.67 Prev Close4.62
ShortableYes LT Debt/Eq0.77 EarningsMay 07 AMC Payout- Avg Volume1.12M Price4.93
Recom1.70 SMA206.70% SMA5019.38% SMA200-2.00% Volume748,180 Change6.82%
Apr-22-20Initiated Northland Capital Outperform $9
Jan-09-20Initiated Piper Sandler Overweight $9
Mar-20-19Initiated SunTrust Buy $7
Jan-31-19Resumed Janney Buy $5
Jan-26-18Initiated Seaport Global Securities Buy $5
Aug-14-17Resumed Cantor Fitzgerald Overweight $4.50
Aug-10-17Reiterated H.C. Wainwright Buy $4 → $5
May-26-17Initiated H.C. Wainwright Buy $4
May-17-17Upgrade Cantor Fitzgerald Neutral → Overweight
May-12-16Reiterated Piper Jaffray Overweight $6 → $4
May-11-16Downgrade Cantor Fitzgerald Buy → Hold
May-04-16Reiterated FBR Capital Outperform $12 → $9
Mar-14-16Reiterated Laidlaw Buy $17 → $11
Mar-11-16Reiterated FBR Capital Outperform $13 → $12
Feb-08-16Initiated Piper Jaffray Overweight
Nov-10-15Reiterated FBR Capital Mkt Perform $17 → $14
Nov-04-15Initiated Cantor Fitzgerald Buy
May-12-15Reiterated Cantor Fitzgerald Buy $17 → $12
May-11-15Reiterated ROTH Capital Buy $16 → $14
Apr-22-15Resumed Piper Jaffray Overweight
May-11-20 08:30AM  BioDelivery Sciences Appoints Jeff Bailey Interim CEO GlobeNewswire -6.50%
May-09-20 05:01PM  Biodelivery Sciences International Inc (BDSI) Q1 2020 Earnings Call Transcript Motley Fool
01:41AM  Edited Transcript of BDSI earnings conference call or presentation 7-May-20 8:30pm GMT Thomson Reuters StreetEvents
May-08-20 10:52AM  BioDelivery (BDSI) Beats on Q1 Earnings, Withdraws Guidance Zacks +5.18%
May-07-20 06:35PM  BioDelivery Sciences International (BDSI) Beats Q1 Earnings and Revenue Estimates Zacks
04:01PM  BioDelivery Sciences Reports Strong Q1 2020 Results GlobeNewswire
Apr-30-20 12:34PM  BioDelivery Sciences International (BDSI) Earnings Expected to Grow: Should You Buy? Zacks
Apr-28-20 08:00AM  BioDelivery Sciences to Report First Quarter 2020 Financial Results on May 7, 2020 GlobeNewswire
Apr-27-20 12:31PM  BioDelivery Sciences International (BDSI) Earnings Expected to Grow: Should You Buy? Zacks +6.19%
Mar-24-20 10:02PM  Edited Transcript of BDSI earnings conference call or presentation 12-Mar-20 8:30pm GMT Thomson Reuters StreetEvents +9.32%
Mar-14-20 08:51AM  Does BioDelivery Sciences International (NASDAQ:BDSI) Have A Healthy Balance Sheet? Simply Wall St.
Mar-13-20 09:29AM  BioDelivery (BDSI) Q4 Earnings and Revenues Beat Estimates Zacks +9.84%
Mar-12-20 08:55PM  BioDelivery Sciences International (BDSI) Tops Q4 Earnings and Revenue Estimates Zacks -5.05%
04:01PM  BioDelivery Sciences Reports Strong Fourth Quarter and Full-Year 2019 Results GlobeNewswire
02:30PM  BioDelivery Sciences International, Inc. to Host Earnings Call ACCESSWIRE
Mar-09-20 08:00AM  BioDelivery Sciences Appoints Jeffrey A. Bailey to its Board of Directors GlobeNewswire -6.05%
Mar-05-20 12:30PM  BioDelivery Sciences International (BDSI) Earnings Expected to Grow: Should You Buy? Zacks
Feb-27-20 05:15PM  BioDelivery Sciences Announces Phase I Clinical Trial Results at the American Academy of Pain Medicines 36th Annual Meeting GlobeNewswire
Feb-24-20 02:59PM  Advance Auto Parts, Cree among Triangle companies hit as stocks tumble with rising concern over coronavirus American City Business Journals -5.58%
Feb-20-20 08:00AM  BioDelivery Sciences to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020 GlobeNewswire
Feb-06-20 10:44AM  Emmaus (EMMA) to Report Q4 Earnings: What's in the Cards? Zacks
Jan-30-20 10:15AM  Alexion (ALXN) Q4 Earnings Beat Estimates, Revenues Up Y/Y Zacks
Jan-29-20 10:06AM  Gilead's Mantle Cell Lymphoma Drug MAA Gets EMA Validation Zacks
Jan-27-20 05:20PM  Here's Why You Should Add BioDelivery Stock to Your Portfolio Zacks
10:25AM  Will Soliris, Ultomiris Drive Alexion's (ALXN) Q4 Earnings? Zacks
Jan-13-20 08:30AM  BDSI Expects Fourth Quarter and 2019 Total Net Sales at the High End of Guidance: Reports Significantly Expanded Insurance Access for Symproic GlobeNewswire
Jan-08-20 12:00PM  What Makes BioDelivery (BDSI) a New Buy Stock Zacks
Jan-06-20 08:30AM  BioDelivery Sciences Appoints Kevin Ostrander as Senior Vice President of Business Development GlobeNewswire
Dec-30-19 09:44AM  Flexion's (FLXN) Stock Up on FDA Approval for Zilretta sNDA Zacks
Dec-27-19 07:53PM  Argo Group, Tivity Health, Horizon Global, and Other 13D Filings Barrons.com -6.52%
Dec-25-19 12:00PM  Are You Looking for a Top Momentum Pick? Why BioDelivery Sciences International (BDSI) is a Great Choice Zacks
Dec-19-19 08:30AM  BioDelivery Sciences Added to NASDAQ Biotechnology Index GlobeNewswire
Dec-12-19 11:30AM  BioDelivery (BDSI) Up 6% Since Last Earnings Report: Can It Continue? Zacks
Dec-10-19 10:48AM  Did Hedge Funds Drop The Ball On BioDelivery Sciences International, Inc. (BDSI) ? Insider Monkey
Dec-06-19 12:00PM  What Makes BioDelivery Sciences International (BDSI) a Strong Momentum Stock: Buy Now? Zacks
Dec-05-19 09:07AM  Zealand Initiates Second Late-Stage CHI Study on Dasiglucagon Zacks
Dec-04-19 11:05AM  Edited Transcript of BDSI earnings conference call or presentation 12-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
10:06AM  Zacks.com featured highlights include: Sciences International, Air Industries, Hallmark Financial Services and Vector Zacks
Dec-03-19 09:16AM  Amarin's Vascepa MAA for Heart Risk Indication Accepted in EU Zacks
08:57AM  5 Affordable Breakout Stocks for Stunning Returns Zacks
Nov-29-19 09:13AM  BioDelivery's Belbuca Sales & Symproic Addition Encouraging Zacks
Nov-27-19 08:30AM  BioDelivery Sciences to Present at the Piper Jaffray 31st Annual Healthcare Conference GlobeNewswire +5.93%
Nov-25-19 08:30AM  BioDelivery Sciences Appoints Dr. Vanila Singh, Former Chief Medical Officer of Health and Human Services, to its Board of Directors GlobeNewswire
Nov-22-19 09:48AM  The Zacks Analyst Blog Highlights: Jounce Therapeutics, BioDelivery Sciences International, Ironwood Pharmaceuticals, Osmotica Pharmaceuticals and Select Medical Zacks
Nov-20-19 10:00AM  What Makes BioDelivery Sciences International (BDSI) a Strong Momentum Stock: Buy Now? Zacks
Nov-19-19 09:26AM  Protalix Finalizes Accelerated Approval Pathway for PRX-102 Zacks
Nov-14-19 10:20AM  BioDelivery (BDSI) Stock Up on Q3 Earnings Beat & Raised View Zacks
Nov-13-19 08:00AM  IVERIC bio (ISEE) Q3 Loss Narrows Y/Y, Zimura Advancing Well Zacks
07:49AM  5 Breakout Stocks for Explosive Returns Zacks
Nov-12-19 05:25PM  BioDelivery Sciences International (BDSI) Beats Q3 Earnings and Revenue Estimates Zacks
04:01PM  BioDelivery Sciences Reports Strong Third Quarter Results, Raises Full Year 2019 and Provides 2020 Net Sales Expectations GlobeNewswire
Nov-07-19 08:00AM  BioDelivery Sciences to Present at the 10th Annual Jefferies Global Healthcare Conference in London GlobeNewswire
Nov-06-19 05:38AM  Introducing BioDelivery Sciences International (NASDAQ:BDSI), The Stock That Zoomed 197% In The Last Three Years Simply Wall St.
Nov-05-19 10:31AM  BioDelivery Sciences International (BDSI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Nov-04-19 11:08AM  The Zacks Analyst Blog Highlights: Unifi, BioDelivery Sciences International, Crocs, Anika Therapeutics and Plexus Zacks
11:01AM  Zacks.com featured highlights include: Universal Forest Products, BioDelivery Sciences International, CBIZ, Euronav and The Bancorp Zacks
Nov-01-19 12:15PM  Were Hedge Funds Right About Selling BioDelivery Sciences International, Inc. (BDSI)? Insider Monkey
08:20AM  5 Stocks With Recent Price Strength to Enhance Your Return Zacks
07:45AM  5 Top Momentum Stocks in October That Still Have Upside Left Zacks
Oct-30-19 10:00AM  Here's Why Momentum Investors Will Love BioDelivery Sciences International (BDSI) Zacks
08:00AM  BioDelivery Sciences to Report Third Quarter 2019 Financial Results and Host Conference Call on November 12, 2019 GlobeNewswire
Oct-18-19 11:07AM  Moving Average Crossover Alert: BioDelivery Sciences International Zacks
08:46AM  Will BioDelivery Sciences Continue to Surge Higher? Zacks
Oct-17-19 08:57AM  New Strong Buy Stocks for October 17th Zacks
Oct-07-19 02:50PM  From Iqvia to Cree: Execs with ties to Triangle companies inked millions in Q3 stock sales American City Business Journals
Oct-01-19 08:00AM  BioDelivery Sciences Announces Significant Additional Insurance Coverage for both BELBUCA® and Symproic® GlobeNewswire
Sep-17-19 04:05PM  BioDelivery Sciences Announces Participation in Upcoming Investor Conferences GlobeNewswire
Sep-07-19 09:30AM  BioDelivery (BDSI) Up 8.9% Since Last Earnings Report: Can It Continue? Zacks
Aug-29-19 08:00AM  BioDelivery Sciences Announces Upcoming Investor Conference Presentations GlobeNewswire
Aug-28-19 07:45AM  BioDelivery Sciences Announces Five Medical Abstracts Accepted at PAINWeek® 2019 National Conference on Pain Management GlobeNewswire
Aug-26-19 08:16PM  $572M ruling in Oklahoma opioid lawsuit could spell trouble for Triangle pharmas American City Business Journals
Aug-16-19 01:41AM  Edited Transcript of BDSI earnings conference call or presentation 8-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-09-19 11:55PM  BioDelivery Sciences International, Inc. (BDSI) Q2 2019 Earnings Call Transcript Motley Fool +7.94%
10:17AM  BioDelivery (BDSI) Earnings & Sales Beat Estimates in Q2 Zacks
Aug-08-19 04:05PM  BioDelivery Sciences Reports Strong Second Quarter 2019 Results and Raises Net Sales Expectations GlobeNewswire +6.61%
01:03PM  How Much Are BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Insiders Taking Off The Table? Simply Wall St.
Aug-01-19 10:33AM  Will BioDelivery Sciences International (BDSI) Report Negative Earnings Next Week? What You Should Know Zacks +5.12%
Jul-30-19 07:45AM  BioDelivery Sciences to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8, 2019 GlobeNewswire
Jul-29-19 01:47PM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating BioDelivery Sciences International, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Jul-25-19 10:15AM  Why a career Triangle pharma executive is bringing a Georgia spin-out to the region American City Business Journals
Jul-17-19 04:30AM  3 Small-Caps That Look Like Bargains at Current Trading Levels TheStreet.com
Jul-09-19 08:00AM  BioDelivery Sciences Announces Further Improved Insurance Coverage for BELBUCA® GlobeNewswire
Jul-03-19 02:19PM  Perrigo Completes Ranir Acquisition, Raises '19 Guidance Zacks
11:46AM  Top Ranked Momentum Stocks to Buy for July 3rd Zacks
10:22AM  Amarin (AMRN) Issues Update on Q2 Sales, Raises '19 Guidance Zacks
Jun-28-19 02:19PM  18 Stocks Joining The Russell Indices Benzinga +5.68%
11:32AM  Zacks.com featured highlights include: BioDelivery, Ciena, United States and Molina Zacks
Jun-27-19 09:18AM  Focus on 4 Liquid Picks on the Top Rung for Robust Returns Zacks
Jun-25-19 09:00AM  What Makes BioDelivery (BDSI) a New Strong Buy Stock Zacks
Jun-24-19 08:00AM  BioDelivery Sciences Expands Upon Report from Pain Management Task Force GlobeNewswire
Jun-21-19 10:37AM  The Zacks Analyst Blog Highlights: Middlesex Water, Atlantic Power, NexPoint Residential Trust, Illumina and BioDelivery Sciences International Zacks
Jun-20-19 09:18AM  5 Top Rate-Sensitive Stocks to Buy Amid Fed's Rate Cut Hints Zacks
08:00AM  BioDelivery Sciences Named to the Russell 3000® Index GlobeNewswire
Jun-19-19 08:43PM  Heres What Hedge Funds Think About BioDelivery Sciences International, Inc. (BDSI) Insider Monkey
Jun-05-19 09:30AM  Why Is BioDelivery (BDSI) Down 12.3% Since Last Earnings Report? Zacks
May-31-19 08:33AM  Triangle company uses new financial strength to lock down favorable loan American City Business Journals
May-29-19 04:10PM  BioDelivery Sciences Announces Upcoming Investor Conference Presentations GlobeNewswire
May-28-19 04:10PM  BioDelivery Sciences Strengthens Financial Position with Debt Refinancing GlobeNewswire
07:46AM  Can You Imagine How Chuffed BioDelivery Sciences International's (NASDAQ:BDSI) Shareholders Feel About Its 108% Share Price Gain? Simply Wall St.
May-23-19 09:19AM  The Zacks Analyst Blog Highlights: Cambrex, Innoviva, Celgene, BioDelivery Sciences International and Unity Biotechnology Zacks
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug-delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; BUNAVAIL, a buprenorphine and naloxone buccal film to treat opioid dependence; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in opioid tolerant adult patients with cancer. The company also develops buprenorphine extended release injection, an injectable microparticle formulation of buprenorphine for the treatment of opioid dependence and chronic pain. BioDelivery Sciences International, Inc. was founded in 1997 and is headquartered in Raleigh, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vollins JamesSee RemarksMay 21Option Exercise3.9021,66684,49721,666May 22 04:04 PM
Vollins JamesSee RemarksMay 21Sale4.6021,66699,6640May 22 04:04 PM
Plesha Scott M.See RemarksMay 18Sale4.5215,00067,800234,003May 20 04:38 PM
ODONNELL FRANCIS E JRDirectorMay 11Option Exercise0.0022,5000628,038May 14 04:07 PM
Sirgo Mark ADirectorMay 11Option Exercise0.0022,50001,287,095May 12 06:48 PM
Sirgo Mark ADirectorMay 08Sale5.07100,000507,0001,264,595May 12 06:48 PM
ODONNELL FRANCIS E JRDirectorMay 06Sale4.5311,25050,963605,538May 08 04:06 PM
Cukier HermChief Executive OfficerMay 04Option Exercise0.0066,6660102,447May 05 04:05 PM
ODONNELL FRANCIS E JRDirectorMay 04Sale4.4516,00071,200616,788May 05 04:06 PM
Sirgo Mark ADirectorApr 27Sale4.58100,000458,0001,364,595Apr 29 04:10 PM
ODONNELL FRANCIS E JRDirectorApr 20Sale4.2220,00084,400632,788Apr 22 04:18 PM
Sirgo Mark ADirectorApr 15Sale4.1350,000206,5001,464,595Apr 17 04:05 PM
Plesha Scott M.See RemarksMar 18Sale3.5515,00053,250249,003Mar 18 04:19 PM
ODONNELL FRANCIS E JRDirectorMar 17Sale3.6330,500110,715656,072Mar 18 04:18 PM
ODONNELL FRANCIS E JRDirectorMar 16Option Exercise0.0077,5000688,754Mar 18 04:18 PM
Plesha Scott M.See RemarksMar 16Option Exercise0.0029,1670243,170Mar 18 04:19 PM
ODONNELL FRANCIS E JRDirectorMar 16Sale3.6038,750139,500686,572Mar 18 04:18 PM
Vollins JamesSee RemarksMar 16Sale3.503,83313,4160Mar 18 04:20 PM
ODONNELL FRANCIS E JRDirectorFeb 03Sale5.318,00042,480548,754Feb 04 07:21 PM
Cukier HermChief Executive OfficerFeb 03Sale5.1631,850164,34635,781Feb 04 07:25 PM
Smith Thomas BChief Medical OfficerJan 31Option Exercise0.007,66607,666Feb 04 07:31 PM
Plesha Scott M.See RemarksJan 31Option Exercise0.0013,3330205,669Feb 04 07:29 PM
Cukier HermChief Executive OfficerJan 31Option Exercise0.0031,250067,631Feb 04 07:25 PM
Vollins JamesSee RemarksJan 31Option Exercise0.003,83303,833Feb 04 07:19 PM
Smith Thomas BChief Medical OfficerJan 31Sale5.382,92715,7474,739Feb 04 07:31 PM
Plesha Scott M.See RemarksJan 21Sale5.7715,00086,550192,336Jan 23 04:28 PM
Coelho Mary TheresaSee RemarksJan 16Sale5.9842,018251,26812,018Jan 17 04:06 PM
Coelho Mary TheresaSee RemarksJan 15Option Exercise2.4654,036133,17254,036Jan 17 04:06 PM
Sirgo Mark ADirectorJan 07Sale5.6513,35375,4441,478,124Jan 09 04:03 PM
Sirgo Mark ADirectorJan 06Sale5.8418,600108,6241,491,477Jan 06 08:48 PM
Sirgo Mark ADirectorJan 03Sale6.0013,85783,1421,510,077Jan 06 08:48 PM
Sirgo Mark ADirectorJan 02Sale6.0954,190330,0171,523,934Jan 06 08:48 PM
ODONNELL FRANCIS E JRDirectorJan 02Sale6.108,00048,800556,754Jan 03 04:23 PM
ODONNELL FRANCIS E JRDirectorDec 26Sale7.0010,00070,000554,754Dec 30 05:40 PM
Broadfin Healthcare Master FunDirectorDec 20Sale6.321,000,0006,320,0002,300,066Dec 20 07:51 PM
Broadfin Healthcare Master FunDirectorDec 18Sale6.491,000,0006,485,0003,300,066Dec 20 07:51 PM
Plesha Scott M.See RemarksDec 11Sale6.3650,000318,000207,336Dec 13 04:07 PM
Cukier HermChief Executive OfficerDec 02Option Exercise2.1838,46183,84574,842Dec 04 04:17 PM
Cukier HermChief Executive OfficerDec 02Sale6.8238,461262,30436,381Dec 04 04:17 PM
ODONNELL FRANCIS E JRDirectorDec 02Sale6.868,00054,880564,754Dec 04 04:13 PM
Broadfin Healthcare Master FunDirectorNov 18Sale5.901,793,75710,584,165300,066Nov 19 09:31 PM
Plesha Scott M.See RemarksNov 18Sale6.0625,000151,500257,336Nov 19 04:36 PM
Vollins JamesSee RemarksNov 15Option Exercise3.4629,825103,19529,825Nov 19 04:39 PM
Vollins JamesSee RemarksNov 15Sale6.0929,825181,6340Nov 19 04:39 PM
Broadfin Healthcare Master FunDirectorNov 15Sale6.042,206,24313,319,0892,093,823Nov 19 09:31 PM
Davis Todd CDirectorNov 15Sale6.11200,0001,222,000237,914Nov 19 04:38 PM
ODONNELL FRANCIS E JRDirectorNov 01Sale5.838,00046,640572,754Nov 05 04:31 PM
ODONNELL FRANCIS E JRDirectorOct 28Option Exercise3.4732,500112,775613,254Oct 30 04:33 PM
ODONNELL FRANCIS E JRDirectorOct 28Sale6.0032,500195,000580,754Oct 30 04:33 PM
Sirgo Mark ADirectorOct 18Sale5.1584,228433,7741,578,124Oct 22 04:36 PM
Sirgo Mark ADirectorOct 17Sale5.1531,860164,0791,662,352Oct 17 05:32 PM
Sirgo Mark ADirectorOct 16Sale5.158,91245,8971,694,212Oct 17 05:32 PM
ODONNELL FRANCIS E JRDirectorOct 15Option Exercise2.2632,50073,450613,254Oct 17 05:26 PM
Sirgo Mark ADirectorOct 15Sale4.98103,321514,5391,703,124Oct 17 05:32 PM
ODONNELL FRANCIS E JRDirectorOct 15Sale5.0032,500162,500580,754Oct 17 05:26 PM
ODONNELL FRANCIS E JRDirectorOct 01Sale4.348,00034,720580,754Oct 03 04:11 PM
Sirgo Mark ADirectorSep 19Sale4.7924,506117,3841,806,445Sep 19 05:02 PM
Sirgo Mark ADirectorSep 18Sale4.7743,686208,3821,830,951Sep 19 05:02 PM
Sirgo Mark ADirectorSep 17Sale4.79157,177752,8781,874,637Sep 19 05:02 PM
ODONNELL FRANCIS E JRDirectorSep 03Sale4.298,00034,320588,754Sep 04 04:08 PM
Watson W. MarkDirectorAug 13Option Exercise0.0024,739035,979Aug 15 04:29 PM
Davis Todd CDirectorAug 13Option Exercise0.0018,1230437,914Aug 15 04:27 PM
KOTLER KEVINDirectorAug 13Option Exercise0.0018,12304,300,066Aug 15 04:28 PM
Greenleaf PeterDirectorAug 13Option Exercise0.0021,144024,788Aug 15 04:25 PM
ODONNELL FRANCIS E JRDirectorAug 01Sale3.828,00030,560596,754Aug 02 04:06 PM
ODONNELL FRANCIS E JRDirectorJul 01Sale4.688,00037,440604,754Jul 03 06:00 PM
Sirgo Mark ADirectorJun 25Sale4.3990,706398,1992,031,714Jun 27 06:00 PM
Sirgo Mark ADirectorJun 12Sale4.21177,495747,2542,122,420Jun 13 06:00 PM
Sirgo Mark ADirectorJun 11Option Exercise3.6884,717311,8172,607,172Jun 13 06:00 PM
Sirgo Mark ADirectorJun 11Sale4.22307,2571,296,6252,299,915Jun 13 06:00 PM
ODONNELL FRANCIS E JRDirectorJun 03Sale4.328,00034,560612,754Jun 05 06:00 PM